MEDI-7352

N/A

Report date: 2025/07/29 11:45:03

Base Information

Drug NameMEDI-7352

Drug Alias NameMEDI-7352

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionTumor necrosis factor modulatorsNerve growth factor modulators

TargetsTumor necrosis factorNerve growth factor

Therapy Area/IndicationsChronic PainDiabetic NeuropathiesOsteoarthritis, Knee

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwedenPolandRomania +[9]

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesMedimmune

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAstrazeneca Plc

Active IndicationsN/A

Inactive IndicationsChronic PainDiabetic NeuropathiesOsteoarthritis, Knee

Other Information

ATC CodeN/A